High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures
Open Access
- 20 June 2022
- journal article
- research article
- Published by Elsevier in Ophthalmology Science
- Vol. 2 (3) , 100188
Abstract
No abstract availableKeywords
Funding Information
- Dutch Cancer Society
- Cancer Centre Amsterdam
This publication has 39 references indexed in Scilit:
- CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico dataBioinformatics, 2013
- Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplificationProceedings of the National Academy of Sciences, 2012
- MYC on the Path to CancerCell, 2012
- Satellite 2 demethylation induced by 5-azacytidine is associated with missegregation of chromosomes 1 and 16 in human somatic cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2012
- RB1, Development, and Cancer2011
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networksBioinformatics, 2009
- Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomasGenes, Chromosomes and Cancer, 2008
- Transcription-independent functions of MYC: regulation of translation and DNA replicationNature Reviews Molecular Cell Biology, 2008
- The epigenetic progenitor origin of human cancerNature Reviews Genetics, 2006
- affy—analysis of Affymetrix GeneChip data at the probe levelBioinformatics, 2004